Anno IPO di China Zhong Qi Hldgs Ltd. è 2019
L'offerta pubblica iniziale è un tipo di offerta pubblica in cui le azioni di una società di solito sono vendute a investitori istituzionali che, a loro volta, vendono al pubblico in generale, su una borsa valori, per la prima volta.
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
024 Pharma, Inc. provides healthcare products worldwide. Its products include vitamin and mineral supplements; stress release, joint, heart health, and weight-loss products; and skin care, hair, and anti-aging products. The company was formerly known as B Green Innovations, Inc. and changed its name to 024 Pharma, Inc. in October 2016. 024 Pharma, Inc. was incorporated in 2004 and is based in West Palm Beach, Florida.